AstraZeneca in $1.15B Deal for Pearl Therapeutics

June 10 (Bloomberg) -- Bloomberg's Anna Edwards reports that AstraZeneca has agreed to a $1.15 billion deal to buy Pearl Therapeutics, a maker of therapies for respiratory disease. She speaks on Bloomberg Television's "Countdown."
Why the Blurry Outlook for Getty Images?
52:38 - March 2 -- Getty Images is caught in a price war that’s sapping profits and undermining investors’ confidence in its finances. Bloomberg’s Laura Keller reports on “Bottom Line.”
  • Sen. Mikulski (D) Says She Won’t Seek Re-Election
  • How Badly Have Sanctions Hurt Iran?
  • NXP Buys Freescale, Biggest Semiconductor Deal in 9 Years